- Home
- FAAS vs IXHL Comparison
FAAS vs IXHL Comparison
Compare FAAS & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FAAS
- IXHL
- Stock Information
- Founded
- FAAS 2021
- IXHL 2001
- Country
- FAAS Indonesia
- IXHL Australia
- Employees
- FAAS N/A
- IXHL N/A
- Industry
- FAAS
- IXHL
- Sector
- FAAS
- IXHL
- Exchange
- FAAS NYSE
- IXHL Nasdaq
- Market Cap
- FAAS 33.4M
- IXHL 39.2M
- IPO Year
- FAAS N/A
- IXHL N/A
- Fundamental
- Price
- FAAS $0.63
- IXHL $1.88
- Analyst Decision
- FAAS
- IXHL
- Analyst Count
- FAAS 0
- IXHL 0
- Target Price
- FAAS N/A
- IXHL N/A
- AVG Volume (30 Days)
- FAAS 1.1M
- IXHL 24.0K
- Earning Date
- FAAS 09-17-2024
- IXHL 11-14-2024
- Dividend Yield
- FAAS N/A
- IXHL N/A
- EPS Growth
- FAAS N/A
- IXHL N/A
- EPS
- FAAS N/A
- IXHL N/A
- Revenue
- FAAS $57,730,593.00
- IXHL $86,000.00
- Revenue This Year
- FAAS N/A
- IXHL $3,817.06
- Revenue Next Year
- FAAS N/A
- IXHL $66.67
- P/E Ratio
- FAAS N/A
- IXHL N/A
- Revenue Growth
- FAAS 38.16
- IXHL N/A
- 52 Week Low
- FAAS $0.38
- IXHL $1.50
- 52 Week High
- FAAS $13.99
- IXHL $8.47
- Technical
- Relative Strength Index (RSI)
- FAAS 45.07
- IXHL 50.66
- Support Level
- FAAS $0.65
- IXHL $1.71
- Resistance Level
- FAAS $0.83
- IXHL $1.93
- Average True Range (ATR)
- FAAS 0.20
- IXHL 0.15
- MACD
- FAAS -0.03
- IXHL 0.00
- Stochastic Oscillator
- FAAS 6.61
- IXHL 35.51
About FAAS DIGIASIA CORP
DigiAsia Corp operates as a holding company. The majority of DigiAsia's operations are currently conducted through its majority-owned entities, controlled entities and corporate joint venture. It is among the first embedded fintech as a service (EFaaS) companies in Indonesia serving business-to-business-to-consumer (B2B2C) customers, such as large corporations and state-owned enterprises, as well as business-to-business (B2B) customers, such as micro, small and medium-sized enterprise (MSME) merchants, across various segments. It aims to be a fintech-enabling platform in Southeast Asia by accelerating financial inclusion through its licenses and technology stack and combining the benefits of technological innovation with traditional financial services.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.